Index by Author

December 2017, Volume 24, Number 12
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. AuYeung, Amanda W K

    • Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer 24 (12) T311-T329, doi:10.1530/ERC-17-0316 first published on 14 September 2017

B

  1. Bridle, Byram W

    • Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer 24 (12) T311-T329, doi:10.1530/ERC-17-0316 first published on 14 September 2017

C

  1. Cheung, Florence S G

    • The role of the tumour microenvironment in immunotherapy Endocr Relat Cancer 24 (12) T283-T295, doi:10.1530/ERC-17-0146 first published on 28 July 2017

  2. Cukier, Priscilla

  3. Cunha, Lucas Leite

    • Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017

G

  1. Gamat, Melissa

    • Androgen deprivation and immunotherapy for the treatment of prostate cancer Endocr Relat Cancer 24 (12) T297-T310, doi:10.1530/ERC-17-0145 first published on 16 August 2017

  2. Gasser, Stephan

    • The role of the tumour microenvironment in immunotherapy Endocr Relat Cancer 24 (12) T283-T295, doi:10.1530/ERC-17-0146 first published on 28 July 2017

H

  1. Hoff, Ana O

K

  1. Karimi, Khalil

    • Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer 24 (12) T311-T329, doi:10.1530/ERC-17-0316 first published on 14 September 2017

L

  1. Lim, Lina H K

    • The role of the tumour microenvironment in immunotherapy Endocr Relat Cancer 24 (12) T283-T295, doi:10.1530/ERC-17-0146 first published on 28 July 2017

M

  1. Marcello, Marjory Alana

    • Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017

  2. McNeel, Douglas G

    • Androgen deprivation and immunotherapy for the treatment of prostate cancer Endocr Relat Cancer 24 (12) T297-T310, doi:10.1530/ERC-17-0145 first published on 16 August 2017

  3. Mould, Robert C

    • Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer 24 (12) T311-T329, doi:10.1530/ERC-17-0316 first published on 14 September 2017

N

  1. Ngeow, Joanne Y Y

    • Cancer immunotherapy: unique perspectives for endocrine-related cancers Endocr Relat Cancer 24 (12) E13-E14, doi:10.1530/ERC-17-0413

R

  1. Rocha-Santos, Vinicius

    • Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017

S

  1. Santini, Fernando C

  2. Scaranti, Mariana

V

  1. van Vloten, Jacob P

    • Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission Endocr Relat Cancer 24 (12) T311-T329, doi:10.1530/ERC-17-0316 first published on 14 September 2017

W

  1. Ward, Laura S

    • Cancer immunotherapy: unique perspectives for endocrine-related cancers Endocr Relat Cancer 24 (12) E13-E14, doi:10.1530/ERC-17-0413

  2. Ward, Laura Sterian

    • Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way Endocr Relat Cancer 24 (12) T261-T281, doi:10.1530/ERC-17-0222 first published on 11 September 2017

New Articles: issue in progress

  1. November 2018, 25 (11)
  1. Alert me to new issues of Endocrine-Related Cancer

Most